Skip to main content
. 2015 Jul 29;7(3):355–357. doi: 10.1111/1759-7714.12298

Figure 1.

figure

(a) Positron emission tomography‐computed tomography (PET/CT) scan before chemoradiotherapy; (b) a CT of the chest revealed the recurrence of lung lesions after the course of chemoradiotherapy; (c) CT scan of chest after two months of crizotinib treatment.